Bloomin’ Brands Inc. (NASDAQ:BLMN) is Attracting Smart Money

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Bloomin’ Brands Inc. (NASDAQ:BLMN) reported that Basham Robert Danker has picked up 6,113,000 of common stock as of 2017-03-31.

The acquisition brings the aggregate amount owned by Basham Robert Danker to a total of 6,113,000 representing a 5.8% stake in the company.

For those not familiar with the company, Bloomin’ Brands, Inc. is a holding company. The Company owns and operates casual, upscale casual and fine dining restaurants. The Company operates through two segments: U.S. and International. The U.S. segment includes all brands operating in the United States. The International segment includes brands operating outside the United States. As of December 25, 2016, the Company had a portfolio of four restaurant concepts: Outback Steakhouse, Carrabba’s Italian Grill, Bonefish Grill, and Fleming’s Prime Steakhouse & Wine Bar. OSI Restaurant Partners, LLC (OSI) is the Company’s primary operating entity. New Private Restaurant Properties, LLC (PRP), an indirect subsidiary of the Company, leases the Company-owned restaurant properties to OSI’s subsidiaries. As of December 25, 2016, the Company owned and operated 1,276 restaurants and franchised 240 restaurants across 48 states, Puerto Rico, Guam and 20 countries.

A glance at Bloomin’ Brands Inc. (NASDAQ:BLMN)’s key stats reveals a current market capitalization of 2.07 Billion based on 102.84 Million shares outstanding and a price at last close of $19.73 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2017-03-10, Singh picked up 120 at a purchase price of $17.65. This brings their total holding to 42,325 as of the date of the filing.

On the sell side, the most recent transaction saw Singh unload 120 shares at a sale price of $17.99. This brings their total holding to 42,205.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Bloomin’ Brands Inc. (NASDAQ:BLMN) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

Opko Health, Inc.. is Buying Vbi Vaccines Inc. (NASDAQ:VBIV) Shares

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Vbi Vaccines Inc. (NASDAQ:VBIV) reported that Opko Health, Inc. has picked up 6,023,014 of common stock as of 2017-03-31.

The acquisition brings the aggregate amount owned by Opko Health, Inc. to a total of 6,023,014 representing a 15.0% stake in the company.

For those not familiar with the company, VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. VBI’s first marketed product is Sci-B-Vac™, a hepatitis B (“HBV”) vaccine that mimics all three viral surface antigens of the hepatitis B virus; Sci-B-Vacis approved for use in Israel and 14 other countries. VBI’s eVLP Platform technology allows for the development of enveloped (“e”) virus-like particle (“VLP”) vaccines that closely mimic the target virus to elicit a potent immune response. VBI is advancing a pipeline of eVLP vaccines, with lead programs in cytomegalovirus (“CMV”) and glioblastoma multiforme (“GBM”). VBI is also advancing its LPV™ Thermostability Platform, a proprietary formulation and process that allows vaccines and biologics to preserve stability, potency, and safety. VBI is headquartered in Cambridge, MA with research operations in Ottawa, Canada and research and manufacturing facilities in Rehovot, Israel.

A glance at Vbi Vaccines Inc. (NASDAQ:VBIV)’s key stats reveals a current market capitalization of 217.34 Million based on 40.02 Million shares outstanding and a price at last close of $5.49 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2016-12-06, Perceptive picked up 3,383,955 at a purchase price of $3.05. This brings their total holding to 6,245,725 as of the date of the filing.

On the sell side, the most recent transaction saw Mcchesney unload 1,500 shares at a sale price of $1.59. This brings their total holding to 0.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Vbi Vaccines Inc. (NASDAQ:VBIV) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

Berg Jeffrey Alan Picked Ntn Buzztime Inc. (NYSEMKT:NTN) Shares

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Ntn Buzztime Inc. (NYSEMKT:NTN) reported that Berg Jeffrey Alan has picked up 423,000 of common stock as of 2017-03-31.

The acquisition brings the aggregate amount owned by Berg Jeffrey Alan to a total of 423,000  representing a 17.03% stake in the company.

For those not familiar with the company, NTN Buzztime, Inc., formerly Alroy Industries, delivers entertainment and dining technology to bars and restaurants in North America. The Company provides an entertainment and marketing services platform for hospitality venues that offers games, events, and entertainment experiences to their customers. Its customers offer guests trivia, card, sports and arcade games, nationwide competitions, and self-service dining features, including dynamic menus, touchscreen ordering and secure payment by licensing the Company’s customizable solution. Its platform creates connections among the players and venues. Its network subscriber venues are related to national and regional restaurant brands, including Buffalo Wild Wings, Old Chicago, Beef O’Brady’s, Aroogas, Buffalo Wings & Rings, Native New Yorker and Boston Pizza. Its entertainment system enables players to interact at the venue, and it also enables competition between venues, referred to as multiplayer gaming.

A glance at Ntn Buzztime Inc. (NYSEMKT:NTN)’s key stats reveals a current market capitalization of 21.70 Million based on 2.26 Million shares outstanding and a price at last close of $8.60 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2016-11-16, Berg picked up 500 at a purchase price of $7.25. This brings their total holding to 423,000 as of the date of the filing.

On the sell side, the most recent transaction saw Awm unload 2,310 shares at a sale price of $8.50. This brings their total holding to 324,191.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Ntn Buzztime Inc. (NYSEMKT:NTN) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

Guess Who Picked Htg Molecular Diagnostics Inc (NASDAQ:HTGM) Shares

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Htg Molecular Diagnostics Inc (NASDAQ:HTGM) reported that Novo A/s has picked up 1,280,185 of common stock as of 2017-03-31.

The acquisition brings the aggregate amount owned by Novo A/s to a total of 1,280,185 representing a 15.9% stake in the company.

For those not familiar with the company, HTG Molecular Diagnostics, Inc. is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company’s HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company’s HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples. The Company’s HTG EdgeSeq chemistry, together with its HTG Edge or HTG EdgeSeq instrumentation and software, automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation. The HTG EdgeSeq system utilizes substantially the same sample preparation reagents as its original chemistry, but allows for read out on an NGS instrument.

A glance at Htg Molecular Diagnostics Inc (NASDAQ:HTGM)’s key stats reveals a current market capitalization of 62.19 Million based on 8.05 Million shares outstanding and a price at last close of $6.92 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2015-08-24, Johnson picked up 1,000 at a purchase price of $5.34. This brings their total holding to 11,718 as of the date of the filing.

On the sell side, the most recent transaction saw Glaxosmithkline unload 300,000 shares at a sale price of $10.15. This brings their total holding to 792,781.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Htg Molecular Diagnostics Inc (NASDAQ:HTGM) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

Here’s Who Just Picked Up Homefed Corp (OTCMKTS:HOFD) Shares

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Homefed Corp (OTCMKTS:HOFD) reported that Leucadia National has picked up 10,838,115 of common stock as of 2017-03-31.

The acquisition brings the aggregate amount owned by Leucadia National to a total of 10,838,115 representing a 70.2% stake in the company.

For those not familiar with the company, HomeFed Corporation is a developer and owner of residential and mixed-use real estate projects in California, Virginia, South Carolina, Florida, Maine and New York. The Company operates through three segments: real estate, farming and corporate. Its real estate operations consist of a range of residential and commercial land development projects and other unimproved land, all in various stages of development, and retail and office operating properties. Real estate also includes the equity method investments in Brooklyn Renaissance Holding Company LLC (BRP Holding) and Brooklyn Renaissance Hotel LLC (BRP Hotel). Its farming operations consist of the Rampage property, which includes an operating grape vineyard. The Company, as the owner of development projects, is engaged in a range of activities, including design engineering, grading raw land, constructing public infrastructure and finishing individual lots for home sites or other facilities.

A glance at Homefed Corp (OTCMKTS:HOFD)’s key stats reveals a current market capitalization of 688.10 Million based on 15.45 Million shares outstanding and a price at last close of $45.00 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2017-03-23, Leucadia picked up 783,889  at a purchase price of $39.95. This brings their total holding to 10,838,115 as of the date of the filing.

On the sell side, the most recent transaction saw Cumming unload 65,704 shares at a sale price of $39.95. This brings their total holding to 0.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Homefed Corp (OTCMKTS:HOFD) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

Watson Jill Foss is Buying Credit Acceptance Corp (NASDAQ:CACC) Shares

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Credit Acceptance Corp (NASDAQ:CACC) reported that Watson Jill Foss has picked up 1,006,323 of common stock as of 2017-03-31.

The acquisition brings the aggregate amount owned by Watson Jill Foss to a total of 1,006,323 representing a 5.1% stake in the company.

For those not familiar with the company, Credit Acceptance Corporation offers financing programs that enable automobile dealers to sell vehicles to consumers. The Company’s financing programs are offered through a network of automobile dealers. The Company has two Dealers financing programs: the Portfolio Program and the Purchase Program. Under the Portfolio Program, the Company advances money to dealers (Dealer Loan) in exchange for the right to service the underlying consumer loans. Under the Purchase Program, the Company buys the consumer loans from the dealers (Purchased Loan) and keeps the amounts collected from the consumer. Dealer Loans and Purchased Loans are collectively referred to as Loans. As of December 31, 2016, the Company’s target market included approximately 60,000 independent and franchised automobile dealers in the United States. The Company has market area managers located throughout the United States that market its programs to dealers, enroll new dealers and support active dealers.

A glance at Credit Acceptance Corp (NASDAQ:CACC)’s key stats reveals a current market capitalization of 412.12 Billion based on 19.88 Million shares outstanding and a price at last close of $199.41 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2016-06-17, Whitman picked up 100 at a purchase price of $166.05. This brings their total holding to 200 as of the date of the filing.

On the sell side, the most recent transaction saw Watson unload 10,000 shares at a sale price of $198.00. This brings their total holding to 853,424.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Credit Acceptance Corp (NASDAQ:CACC) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

Atzmon Menachem Picked Icts International N V (OTCMKTS:ICTSF) Shares

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Icts International N V (OTCMKTS:ICTSF) reported that Atzmon Menachem has picked up 3,000,000 of common stock as of 2017-03-31.

The acquisition brings the aggregate amount owned by Atzmon Menachem to a total of 3,000,000 representing a 14.29% stake in the company.

For those not familiar with the company, ICTS International N.V. (ICTS) is engaged in the provision of aviation security and other aviation services. The Company operates in three segments: corporate, airport security and other aviation services, and technology. The airport security and other aviation services segment provide security and other services to airlines and airport authorities, predominantly in Europe and the United States. The technology segment is involved in the development and sale of identity security software to financial and other institutions, in Europe and the United States. ICTS, through its subsidiary, Huntleigh USA, Corp. (Huntleigh), engages primarily in non-security related activities in the United States. ICTS, through I-SEC International Security B.V. (I-SEC) and its subsidiaries, supplies aviation security services at airports in Europe and the Far East. ICTS, through Au10tix Ltd. (Au10Tix) and AU10TIX B.V., develops technological systems and solutions for financial and other institutions.

A glance at Icts International N V (OTCMKTS:ICTSF)’s key stats reveals a current market capitalization of 4.93 Million based on 10.96 Million shares outstanding and a price at last close of $0.450 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2016-12-06, Atzmon picked up 1,500,000 at a purchase price of $0.40. This brings their total holding to 3,000,000 as of the date of the filing.

On the sell side, the most recent transaction saw Atzmon unload 128,840 shares at a sale price of $2.10. This brings their total holding to 0.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Icts International N V (OTCMKTS:ICTSF) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

Retractable Technologies Inc. (NYSEMKT:RVP) is Attracting Smart Money

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Retractable Technologies Inc. (NYSEMKT:RVP) reported that Bml Investment Partners, L.p. has picked up 1,959,059 of common stock as of 2017-03-31.

The acquisition brings the aggregate amount owned by Bml Investment Partners, L.p. to a total of 1,959,059 representing a 6.6% stake in the company.

For those not familiar with the company, Retractable Technologies, Inc. designs, develops and manufactures safety medical products for the healthcare industry. The Company markets VanishPoint and PatientSafe products. The VanishPoint products are designed specifically to prevent needle stick injuries and to prevent reuse. The VanishPoint safety products include tuberculin, insulin and allergy antigen VanishPoint syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL and 10mL VanishPoint syringes, and the VanishPoint autodisable syringe. It also sells the VanishPoint intravenous catheter, the VanishPoint blood collection tube holder and the VanishPoint blood collection set. The PatientSafe syringe reduces the risk of bloodstream infections resulting from catheter hub contamination. Its PatientSafe products include 3mL, 5mL, 10mL, 20mL, 30mL and 60mL syringes, and the PatientSafe Luer cap. Its product designs include retractable needle syringe designs, retractable needle designs and retractable needle dental syringe designs.

A glance at Retractable Technologies Inc. (NYSEMKT:RVP)’s key stats reveals a current market capitalization of 31.60 Million based on 29.65 Million shares outstanding and a price at last close of $1.08 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2017-01-12, Shaw picked up 2,000,000 at a purchase price of $0.89. This brings their total holding to 12,065,642 as of the date of the filing.

On the sell side, the most recent transaction saw Mack unload 100 shares at a sale price of $1.42. This brings their total holding to 0.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Retractable Technologies Inc. (NYSEMKT:RVP) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

Skip to content